• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 455

Bifidobacterium breve M-16V

Intended Use: As an ingredient in exempt term powdered amino acid-based formulas, at levels providing 108 colony forming units per gram of infant formula powder
Basis: Scientific procedures
Notifier: Danone Trading B.V.
Notifier Address: Schiphol Boulevard 105
1118 BG Schiphol Airport
Date of filing: Jan 23, 2013
GRAS Notice (releasable information): GRN 455 (in PDF) (15.1 MB)
Date of closure: Sep 30, 2013
FDA's Letter: FDA has no questions